Oruka Therapeutics, Inc. Balance Sheet
ORKA / Health Care|15 years of annual SEC 10-K data (FY2010-FY2024)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
Oruka Therapeutics, Inc. had $1,000 in total assets and $1,000 in shareholders' equity as of FY2024.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $61.6M | $37.4M | $42.4M | $53.4M | $49.1M | $8.4M | $8.7M | $7.4M | $38.8M | $15.4M | $16.8M | $16.8M | $2.9M | $5.9M | $7.0M |
| Current Assets | $1.0K | $37.6M | $42.7M | $54.4M | $50.0M | $8.5M | $6.8M | $12.3M | $21.4M | $38.9M | $15.5M | $16.9M | $3.0M | $6.2M | $7.2M |
| PP&E (Net) | $162.0K | $10.0K | $25.0K | $48.0K | $21.0K | $10.0K | $24.0K | $42.0K | $66.0K | $28.0K | $36.0K | $29.0K | $23.0K | $66.0K | $690.0K |
| Total Assets | $1.0K | $37.9M | $43.1M | $54.9M | $50.4M | $8.5M | $6.8M | $12.4M | $24.6M | $39.6M | $16.1M | $17.1M | $3.2M | $6.5M | $8.2M |
| Current Liabilities | $13.0M | $637.0K | $1.1M | $3.5M | $3.5M | $926.0K | $793.0K | $2.1M | $2.4M | $1.5M | $1.4M | $1.5M | $305.0K | $754.0K | $1.2M |
| Shareholders' Equity | $1.0K | $37.0M | $51.0M | $46.5M | $7.6M | $6.0M | $10.3M | $22.2M | $38.1M | $14.7M | $15.6M | $15.6M | $2.9M | $5.7M | $6.8M |